We serve Chemical Name:3-heptyl-5-methyloxolan-2-one CAS:40923-64-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-heptyl-5-methyloxolan-2-one
CAS.NO:40923-64-6
Synonyms:FEMA No. 3350;3-Heptyl-5-methyl-dihydro-furan-2-on;3-heptyl-5-methyl-dihydro-furan-2-one;EINECS 255-141-2
Molecular Formula:C12H22O2
Molecular Weight:198.30200
HS Code:2932209090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:289.7ºC at 760 mmHg
Density:0.916g/cm3
Index of Refraction:1.443
PSA:26.30000
Exact Mass:198.16200
LogP:3.29850
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like FEMA No. 3350 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 255-141-2 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,FEMA No. 3350 Use and application,EINECS 255-141-2 technical grade,usp/ep/jp grade.
Related News: When using the raw materials, as an API manufacturer we produce API in the large reactor in our plant. 3-heptyl-5-methyloxolan-2-one manufacturer Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress. 3-heptyl-5-methyloxolan-2-one supplier Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. 3-heptyl-5-methyloxolan-2-one vendor Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress. 3-heptyl-5-methyloxolan-2-one factory Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management, Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.
